Icon releases Flex Advantage to support adaptive trial design

By Melissa Fassbender

- Last updated on GMT

Image: iStock
Image: iStock
ICON has announced Flex Advantage, its next-generation Interactive Response Technology (IRT) platform, as sponsors and investigators continue to embrace adaptive trial designs.

In response to our client’s needs, we have updated our IRT platform to be more efficient by utilizing a modular system architecture with reusable functionality​,” Dr. Malcolm Burgess, Executive VP, Interactive Technologies, ICON, told Outsourcing-Pharma.com.

The new platform offers enhanced randomization and clinical supply management capabilities to support adaptive trial execution – a practice which, according to Tufts​, can save companies millions each year.

These changes allow for faster implementation coupled with increased quality,​” added Burgess.

 “The updates were completed in order to upgrade our technology base and to give us a database structure that would allow us to seamlessly integrate with other technologies in the clinical supply ecosystem. This includes linkages to statistical applications to enable adaptive trial support​.”

Adaptive trial designs

The main benefit of the new platform is its flexible randomization engine that can be adjusted mid study. For example, treatment arms can be added or removed as appropriate after an interim analysis.

According to Burgess, this enables adaptive clinical studies while protecting the blind and maintaining data integrity, which has been a major concern for adaptive trial adoption in the past.

Unblinded statisticians can log in and review or even download patient data, the interface then allows them to adjust the randomization design if appropriate​,” he added.

Additionally, the company has developed what it calls the Adaptive Execution Environment, which allows execution of interim and final analyses in a controlled environment with full action traceability.

All programs needed for an interim analysis are prepared by statisticians or statistical programmers in advance and can be invoked via the web interface of the Adaptive Execution Environment as appropriate during the course of the trial​,” explained Burgess.

This allows users to review results, log files, and audit information of all interim analyses at any time. It also eliminates manual data hand-overs for data consistency and reduces the time needed for the analysis.

Analysis results are then available to authorized team members either for on-line review or download before a decision is made and the changes implemented via the Adaptive Execution Environment.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us